Skip to content

Laparoscopic fundoplication for gastroesophageal reflux disease: A prospective study on reflux control and gastroesophageal motility

Laparoscopic fundoplication for gastroesophageal reflux disease: A prospective study on reflux control and gastroesophageal motility - Antireflux surgery in pediatric GERD patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON38094
Enrollment
55
Registered
2009-06-09
Start date
2011-08-11
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

reflux disease vomiting

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
2 Years to 17 Years

Inclusion criteria

Inclusion criteria: Children (0-18 years) with gastroesophageal reflux disease (GERD) in whom 1. antireflux surgery is indicated by a pediatrician/pediatric gastroenterologist and 2. therapy-resistent or recurrent pathological gastroesophageal reflux is proven and 3. written informed consent can be obtained (In patients 12 yrs and mentally able, informed consent will be obtained from the parents/guardians and patients themselves)

Exclusion criteria

Exclusion criteria: - Inability to undergo investigation - prior esophageal and/or gastric surgery, except gastrostoma

Design outcomes

Primary

MeasureTime frame
1. Percentage of failed antireflux procedures - percentage time pH 4%) - amount of reflux episodes/24hr ( > 9 ) - amount of reflux episodes longer than 5 minutes ( > 4 ) - symptom scores (symptoms >= moderate-severe and/or daily-weekly) 2. gastroesophageal function/motility - lower esophageal sphincter relaxation (% complete relaxation) - percentage peristaltic contractions esophagus (%) - contractions proximal/mid/distal esophagus (mmHg) - gastric half-emptying time (min) - proximal gastric adaptive relaxation (ml) Success is defined as a. complete symptom relief and normalised pH metry b. complete symptom relief and near-normal pH metry c. normalized pH metry and significant improvement of reflux symptoms (complaints less than mild/monthly)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)